ENvue Medical, Inc. (FEED)
NASDAQ (NMS) NASDAQ (NMS) Primary Summary
ENvue Medical, Inc. (FEED) FAQ
What is the stock price today?
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
Has ENvue Medical, Inc. ever had a stock split?
ENvue Medical, Inc. Profile
| Household Durables Industry | Consumer Discretionary Sector | Doron Robert Besser CEO | NASDAQ (NMS) Exchange | 63008J884 CUSIP |
| US Country | 31 Employees | - Last Dividend | 12 Aug 2025 Last Split | - IPO Date |
Overview
NanoVibronix, Inc. is a pioneering company specializing in the creation of noninvasive biological response-activating devices that enhance patient treatment experiences. Founded in September 2003 by Harold Jacob and Jona Zumeris, the company is headquartered in Tyler, Texas, and serves various international markets, including the United States, Europe, Australia, India, Israel, and other regions. NanoVibronix is committed to leveraging innovative technology for medical advancements, particularly in the realms of pain management and urinary health.
Products and Services
- UroShield
This product is designed to prevent catheter-associated urinary tract infections (CAUTIs) by using a unique noninvasive technology, which creates a protective barrier around the catheter. The UroShield aims to enhance patient comfort and decrease the risk of infections, ultimately improving health outcomes for individuals needing catheterization.
- PainShield
PainShield is a noninvasive device developed to provide symptomatic relief from various types of pain. Utilizing biophysical principles, this product helps stimulate the body's natural healing processes, reducing pain without the need for medication. It is particularly beneficial for patients seeking alternative pain management solutions that do not involve pharmacological treatments.
